Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000187433 | SCV000202737 | likely benign | not specified | 2017-04-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001704111 | SCV000241023 | likely benign | not provided | 2020-09-24 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000552489 | SCV000660420 | benign | Rett syndrome, congenital variant | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002415649 | SCV002725667 | likely benign | Inborn genetic diseases | 2017-09-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001704111 | SCV002822132 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | FOXG1: PP2, BS1 |
Prevention |
RCV003927481 | SCV004742303 | likely benign | FOXG1-related condition | 2023-09-03 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |